| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/24/2008 | US20080096239 Orphan Nuclear Receptor |
| 04/24/2008 | US20080096222 Compositions And Methods Based Upon The Kinase Haspin |
| 04/24/2008 | US20080096219 Biological Molecule-Immobilized Chip and Its Use |
| 04/24/2008 | US20080096217 Methods for evaluating pathologic conditions using extracellular RNA |
| 04/24/2008 | US20080096215 Using sulfatase gene expression as evaluative tool in detection, prevention and treatment of cell proliferative disorders |
| 04/24/2008 | US20080096211 Expression vector comprising nucleotide sequences coding stability gene expression or protein secretion/folding (SES) proteins for enhancing production of functional heterologous polypeptides |
| 04/24/2008 | US20080096210 Cancer suppressing agent |
| 04/24/2008 | US20080096206 Polynucleotide Sequencing Using a Helicase |
| 04/24/2008 | US20080096191 Methods and systems for detection and isolation of a nucleotide sequence |
| 04/24/2008 | US20080095915 Delta-8 Desaturases And Their Use In Making Polyunsaturated Fatty Acids |
| 04/24/2008 | US20080095889 Nucleotide sequences coding enzymatic polypeptide for use in the preparation of bread doughs |
| 04/24/2008 | US20080095833 Immunogens; expression cassettes; gag genes; tat proteins; DNA vaccines; vpr genes; rev genes; envelope genes; antigen presenting cells; liposomes |
| 04/24/2008 | US20080095819 Antiproliferative agents; connexins; reducing density of astrocytes; increasing density of neurons; hair growth; cosmetic surgery |
| 04/24/2008 | US20080095804 Two-step immunization procedure against chlamydia infection |
| 04/24/2008 | US20080095796 IBD virus TY2 strain or a passage strain of said viral strain allows for production of a vaccine that is efficacious to IBD variant viral strains that may have new properties not protectable by the conventional vaccines |
| 04/24/2008 | US20080095793 Expression vector comprising nucleotide sequences coding protein fusion for use in treatment and prevention of microorganismal infection |
| 04/24/2008 | US20080095792 Polypeptides For Inducing A Protective Immune Response Against Staphylococcus Aureus |
| 04/24/2008 | US20080095788 Vaccines |
| 04/24/2008 | US20080095780 Binding Molecules For Treatment And Detection Of Cancer |
| 04/24/2008 | US20080095773 Polypeptides homologous to vegf and bmp1 |
| 04/24/2008 | US20080095772 Antibodies against human parathyroid hormone related protein |
| 04/24/2008 | US20080095770 Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof |
| 04/24/2008 | US20080095762 Glycoprotein compositions |
| 04/24/2008 | US20080095761 Using steroid alkaloid cyclopamine to treat and prevent tumor progression in urogenital system |
| 04/24/2008 | US20080095747 Promotion of Cell Migration and Axon Regeneration in the Cns |
| 04/24/2008 | US20080093229 MOSFET; microfluidics; biochemical immobilization |
| 04/24/2008 | DE19718640B4 Anwendung eines orange-fluoreszierenden Proteins und weiterer farbiger Proteine aus der Artengruppe Anemonia sp. Application of an orange-colored fluorescent protein and other proteins from the group of species Anemonia sp. (sulcata) Pennant, (Cnidaria, Anthozoa, Actinaria) in Gentechnologie und Molekularbiologie (Sulcata) Pennant (Cnidaria, Anthozoa, Actinaria) in genetics and molecular biology |
| 04/24/2008 | DE102006048882A1 Allele des rel-Gens aus coryneformen Bakterien Alleles of the rel gene from coryneform bacteria |
| 04/24/2008 | CA2699434A1 Stroma derived predictor of breast cancer |
| 04/24/2008 | CA2667636A1 Ssl7 mutants and uses therefor |
| 04/24/2008 | CA2667055A1 Antisense compounds |
| 04/24/2008 | CA2667043A1 Multiple mutation variants of serine protease |
| 04/24/2008 | CA2667030A1 Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides |
| 04/24/2008 | CA2666809A1 Anti-cancer agent comprising anti-hb-egf antibody as active ingredient |
| 04/24/2008 | CA2666657A1 Nicked or gapped nucleic acid molecules and uses thereof |
| 04/24/2008 | CA2666559A1 Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient |
| 04/24/2008 | CA2666458A1 Antibody molecules which bind il-17a and il-17f |
| 04/24/2008 | CA2666357A1 Enhancing disease resistance against rna viral infections with intracytoplasmic pathogen sensors |
| 04/24/2008 | CA2666019A1 Proteins involved in after-cooking darkening in potatoes |
| 04/24/2008 | CA2665528A1 Diagnosis and treatment of cancer using anti-ereg antibody |
| 04/24/2008 | CA2657273A1 Kex2 cleavage regions of recombinant fusion proteins |
| 04/23/2008 | EP1914755A1 Molehole embedded 3-D crossbar architecture used in electrochemical molecular memory device |
| 04/23/2008 | EP1914554A2 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine-1 (MIC-1) |
| 04/23/2008 | EP1914319A2 Polymorphisms and new genes in the region of the human hemochromatosis gene |
| 04/23/2008 | EP1914318A1 Method of detecting large bowel cancer marker |
| 04/23/2008 | EP1914316A2 Microorganisms and cells for diagnosis and therapy of tumors |
| 04/23/2008 | EP1914312A2 Virulence genes and proteins, and their use |
| 04/23/2008 | EP1914311A1 Extracellular matrix proteins with modified amino acid |
| 04/23/2008 | EP1914310A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/23/2008 | EP1914309A1 Method of assaying HIV-1 tropism for CCR5 and/or CXCR4 co-receptor and/or susceptibility to entry inhibitors |
| 04/23/2008 | EP1914308A1 Cold-hardy plant and method for development of the same |
| 04/23/2008 | EP1914305A1 GSK3 polypeptides |
| 04/23/2008 | EP1914304A1 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
| 04/23/2008 | EP1914303A1 Thermus eggertssonii DNA polymerases |
| 04/23/2008 | EP1914302A2 Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics |
| 04/23/2008 | EP1914301A1 Anti-CD80 antibodies |
| 04/23/2008 | EP1914299A2 Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of M.bovis BCG and M.microti |
| 04/23/2008 | EP1914244A2 Method of modulating the activity of functional immune molecules |
| 04/23/2008 | EP1914243A2 Anti-CD40 monoclonal antibody |
| 04/23/2008 | EP1914241A1 Peptide inhibitors of cyclin-dependent kinase activity and uses thereof |
| 04/23/2008 | EP1914238A2 Methods for measuring physical characteristics of nucleic acids by microscope imaging |
| 04/23/2008 | EP1913813A1 Transgenic Mouse for screening and for studies of the pharmacodynamics and pharmacokinetics of ligands acting on intracellular receptors, and method for the preparation thereof |
| 04/23/2008 | EP1913397A1 Graded expression of snail as marker of cancer development and dna damage-based diseases |
| 04/23/2008 | EP1913160A2 Diagnostic methods for the prediction of therapeutic success, recurrence free and overall survival in cancer therapy |
| 04/23/2008 | EP1913149A2 Targeted integration and expression of exogenous nucleic acid sequences |
| 04/23/2008 | EP1913144A1 Molecular variant fibrinogen fusion proteins |
| 04/23/2008 | EP1913143A1 Improved protein expression |
| 04/23/2008 | EP1913142A2 Delta 6 desaturase from thraustochytrid and uses thereof |
| 04/23/2008 | EP1913141A2 Sirna microbicides for preventing and treating viral diseases |
| 04/23/2008 | EP1913140A2 Method for carrying out the selective evolution of proteins in vitro |
| 04/23/2008 | EP1913139A1 Methods for carrying out the selective evolution of proteins in vivo |
| 04/23/2008 | EP1913137A1 Serine beta-lactamase-like / d-aia carboxypeptidase-like protein |
| 04/23/2008 | EP1913136A1 Fusion proteins between plant cell-wall degrading enzymes, and their uses |
| 04/23/2008 | EP1913134A1 Sulfate adenyltransferase gene and use thereof |
| 04/23/2008 | EP1913133A1 Phosphoadenylyl sulfate reductase gene and use thereof |
| 04/23/2008 | EP1913023A1 Novel anticoagulant polypeptides and complex |
| 04/23/2008 | EP1913021A2 Polypeptides having an activity in the mtbe degradation path and uses thereof |
| 04/23/2008 | EP1913020A1 Immunogenic constructs |
| 04/23/2008 | EP1912679A2 Amine-containing lipids and uses thereof |
| 04/23/2008 | EP1912675A2 B-cell reduction using cd37-specific and cd20-specific binding molecules |
| 04/23/2008 | EP1912665A2 Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus |
| 04/23/2008 | EP1912494A1 Isolation of the t-complex distorters and applications thereof |
| 04/23/2008 | EP1774033A4 Multiplexing assays for analyte detection |
| 04/23/2008 | EP1723488A4 Glyphosate tolerant plants and methods of making and using the same |
| 04/23/2008 | EP1699822B1 Il-7 fusion proteins with antibody portions, their preparation and their use |
| 04/23/2008 | EP1644505B1 A yeast model for amyloidogenic protein toxicity |
| 04/23/2008 | EP1606387A4 Vectors used to create hybrid constant regions |
| 04/23/2008 | EP1581094A4 Kits and methods for assessing skin health |
| 04/23/2008 | EP1558722B1 Process for expression and secretion of proteins by the non-conventional yeast zygosaccharomyces bailii |
| 04/23/2008 | EP1462457B1 Cytotoxic protein and utilization thereof |
| 04/23/2008 | EP1456413B1 Method of detection of prostate cancer |
| 04/23/2008 | EP1434858B1 Method for the amplification of a poxvirus under serum free conditions |
| 04/23/2008 | EP1422243B1 Humanized antibody against fibroblast growth factor-8 and fragment of the antibody |
| 04/23/2008 | EP1420643B1 Enhancement of transfection of dna into the liver |
| 04/23/2008 | EP1412531B1 Il-4 receptor sequence variation associated with type 1 diabetes |
| 04/23/2008 | EP1411116B1 Peptide synthase gene, peptide synthase and process for producing dipeptide |
| 04/23/2008 | EP1407025B1 Process for the preparation of l-threonine using strains of the enterobacteriaceae family which contain an enhanced male gene |
| 04/23/2008 | EP1373529B1 Tau-opathy model |
| 04/23/2008 | EP1354889B1 Transcription activation complex and utilization thereof |
| 04/23/2008 | EP1344829B1 Paramyxovirus vector encoding fibroblast growth factor 2 (fgf2) and use thereof |